Spravato®Verificado en registro oficialModelo de centros designados

Privatklinik Meiringen

Meiringen, Suiza

Tratamiento y acceso

Registros relacionados

Estos registros pertenecen a la misma organización. Se listan por separado porque cada uno es un programa o una ubicación distinta.

Sobre este proveedor

Los detalles a continuación están en inglés.

Privatklinik Meiringen is a private psychiatric clinic in the Bernese Oberland (Willigen, Meiringen) with core competencies in depression, alcohol and medication dependence and stress-related illness/burnout. Among its extended therapy procedures it explicitly offers ketamine therapy: intravenous and nasal ketamine as well as S-ketamine (Swissmedic-approved since 2020) for patients with treatment-resistant depression, with close monitoring and careful medical assessment of the indication; the same programme mentions participation options in a multicenter study of oral extended-release ketamine. The clinic also runs centres for old-age psychiatry, behavioural addictions and burnout.

Servicios y programas

Los detalles a continuación están en inglés.

  • Ketamine therapy (intravenous and nasal) and S-ketamine for treatment-resistant depression
  • Extended therapy procedures programme
  • Inpatient treatment of depression, alcohol and medication dependence
  • Centre for stress-related illness/burnout
  • Centre for behavioural addictions
  • Centre for old-age psychiatry
  • Psychiatry centre for young adults (PZJE Thun)
  • Outpatient services and mother-child care option

Preguntas frecuentes

Los detalles a continuación están en inglés.

Who decides whether I can receive ketamine or esketamine at Privatklinik Meiringen?

Per the clinic, the indication is carefully assessed and weighed by its physicians, and treatments are closely monitored; a named senior physician is listed as contact via the main line +41 33 972 81 11. Referral by your treating psychiatrist is the standard route.

What insurance conditions apply for the nasal spray (Spravato)?

Under the BAG Limitatio, basic insurance covers esketamine nasal spray for adults 18-74 with treatment-resistant depression (at least two antidepressants with different mechanisms plus one augmentation attempt failed, confirmed severity) only after the insurer's cost approval (Kostengutsprache), for a maximum of 10 months.

¿Considerando alternativas? One of the BAG-designated Spravato centers in Switzerland; see the country guide and the limited-medical-use PAT program.

Verificación

Este registro se tomó directamente de un registro oficial o una lista de programa y se revisa de nuevo con una cadencia continua.

¿Detectó un error? Vea nuestra metodología (en inglés) — allí se explica cómo se comprueban los registros y cómo notificar una corrección.